http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#Head
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#assertion
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#provenance
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#pubinfo
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#assertion
http://purl.obolibrary.org/obo/DOID_6364
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_6364
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00953
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
http://www.w3.org/2000/01/rdf-schema#label
rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old information related to usage of rizatriptan benzoate in pediatric patients 6 to 17 years old is approved for merck co inc s rizatriptan benzoate tablets however due to merck co inc s marketing exclusivity rights this drug product is not labeled with that pediatric patient 6 to 17 years old usage information limitations of use rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established if a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets is administered to treat any subsequent attacks rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine see contraindications 4 rizatriptan benzoate tablets are not indicated for the prevention of migraine attacks safety and effectiveness of rizatriptan benzoate tablets have not been established for cluster headache rizatriptan benzoate tablets are a serotonin 5 ht 1b 1d receptor agonist triptan indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age 1 limitations of use use only after clear diagnosis of migraine has been established 1 not indicated for the prophylactic therapy of migraine 1 not indicated for the treatment of cluster headache 1
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00953
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#provenance
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#pubinfo
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig
http://purl.org/nanopub/x/hasSignature
SHw4CdNO17XpNsd8dH0OWSlo+yxnKyXDFY0A2WNUCTJkmDlFZtZ7/6hoMxWY1umKWNcZArozuz+XHIGjXpFAd7EjbJ/VWiVTph8hDPlk8Dt0HD+NqK/VX3dIw5vOuiE6Ulv0Sbtl/sRapEBFcS8RjlUG/mijDIOZdjs4AmZFDuY=
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
http://purl.org/dc/terms/created
2021-06-14T08:58:30.606+02:00
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs